Electricity-Enhanced Lewis Acid-Catalyzed Asymmetric Radical Reactions
Accounts of Chemical Research · 18.11.2025 · 58 (22) · 3427-3441
DOI: 10.1021/acs.accounts.5c00635 ↗Kurz gefasst
Fachartikel in der Zeitschrift Accounts of Chemical Research, online erschienen am 07.11.2025. Verfasst von Minghao Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Hefei National Laboratory for Physical Sciences at the Microscale and Department of Chemistry, University of Science and Technology of China, Hefei 2…. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 73 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Nanjing University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Hefei National Laboratory for Physical Sciences at the Microscale and Department of Chemistry, University of Science and Technology of China, Hefei 230026, China.
- State Key Laboratory of Coordination Chemistry, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210093, China.
ORCID-Profile: Minghao Liu, Chang Guo
Förderung
- National Key Research and Development Program of China
- Nanjing University
- National Natural Science Foundation of China
- State Key Laboratory of Coordination Chemistry
- Chinese Academy of Sciences
Zitieren
APA
Liu, M., & Guo, C. (2025). Electricity-Enhanced Lewis Acid-Catalyzed Asymmetric Radical Reactions. Accounts of Chemical Research, 58(22), 3427-3441. https://doi.org/10.1021/acs.accounts.5c00635
Vancouver
Liu M, Guo C. Electricity-Enhanced Lewis Acid-Catalyzed Asymmetric Radical Reactions. Accounts of Chemical Research. 2025;58(22):3427-3441. doi:10.1021/acs.accounts.5c00635
BibTeX
@article{Liu2025,
author = {Liu, Minghao and Guo, Chang},
title = {Electricity-Enhanced Lewis Acid-Catalyzed Asymmetric Radical Reactions},
journal = {Accounts of Chemical Research},
year = {2025},
volume = {58},
number = {22},
pages = {3427--3441},
doi = {10.1021/acs.accounts.5c00635}
}
EUVIMED